FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2968778744> ?p ?o ?g. }

• W2968778744 endingPage "e1286" @default.
• W2968778744 startingPage "e1280" @default.
• W2968778744 abstract "BackgroundThere is ongoing debate on the clinical benefits of antibiotic prophylaxis for reducing pelvic infection after miscarriage surgery. We aimed to study the cost-effectiveness of antibiotic prophylaxis in the surgical management of miscarriage in low-income countries.MethodsWe did an incremental cost-effectiveness analysis using data from 3412 women recruited to the AIMS trial, a randomised, double-blind, placebo-controlled trial designed to evaluate the effectiveness of antibiotic prophylaxis in the surgical management of miscarriage in Malawi, Pakistan, Tanzania, and Uganda. Economic evaluation was done from a health-care-provider perspective on the basis of the outcome of cost per pelvic infection avoided within 2 weeks of surgery. Pelvic infection was broadly defined by the presence of clinical features or the clinically identified need to administer antibiotics. We used non-parametric bootstrapping and multilevel random effects models to estimate incremental mean costs and outcomes. Decision uncertainty was shown via cost-effectiveness acceptability frontiers. The AIMS trial is registered with the ISRCTN registry, number ISRCTN97143849.FindingsBetween June 2, 2014, and April 26, 2017, 3412 women were assigned to receive either antibiotic prophylaxis (1705 [50%] of 3412) or placebo (1707 [50%] of 3412) in the AIMS trial. 158 (5%) of 3412 women developed pelvic infection within 2 weeks of surgery, of whom 68 (43%) were in the antibiotic prophylaxis group and 90 (57%) in the placebo group. There is 97–98% probability that antibiotic prophylaxis is a cost-effective intervention at expected thresholds of willingness-to-pay per additional pelvic infection avoided. In terms of post-surgery antibiotics, the antibiotic prophylaxis group was US$0·27 (95% CI −0·49 to −0·05) less expensive per woman than the placebo group. A secondary analysis, a sensitivity analysis, and all subgroup analyses supported these findings. Antibiotic prophylaxis, if implemented routinely before miscarriage surgery, could translate to an annual total cost saving of up to $1·4 million across the four participating countries and up to $8·5 million across the two regions of sub-Saharan Africa and south Asia.InterpretationAntibiotic prophylaxis is more effective and less expensive than no antibiotic prophylaxis. Policy makers in various settings should be confident that antibiotic prophylaxis in miscarriage surgery is cost-effective.FundingUK Medical Research Council, Wellcome Trust, and the UK Department for International Development." @default.
• W2968778744 created "2019-08-22" @default.
• W2968778744 creator A5001697249 @default.
• W2968778744 creator A5015999349 @default.
• W2968778744 creator A5023451391 @default.
• W2968778744 creator A5028161835 @default.
• W2968778744 creator A5029342829 @default.
• W2968778744 creator A5034327769 @default.
• W2968778744 creator A5041811964 @default.
• W2968778744 creator A5045009552 @default.
• W2968778744 creator A5045595046 @default.
• W2968778744 creator A5056664128 @default.
• W2968778744 creator A5080359087 @default.
• W2968778744 creator A5085384499 @default.
• W2968778744 creator A5086877004 @default.
• W2968778744 creator A5087241179 @default.
• W2968778744 creator A5087495070 @default.
• W2968778744 date "2019-09-01" @default.
• W2968778744 modified "2023-10-14" @default.
• W2968778744 title "Antibiotic prophylaxis in the surgical management of miscarriage in low-income countries: a cost-effectiveness analysis of the AIMS trial" @default.
• W2968778744 cites W1528748012 @default.
• W2968778744 cites W1535799436 @default.
• W2968778744 cites W1606709542 @default.
• W2968778744 cites W169668689 @default.
• W2968778744 cites W1972388955 @default.
• W2968778744 cites W1985515327 @default.
• W2968778744 cites W1998677430 @default.
• W2968778744 cites W2009260179 @default.
• W2968778744 cites W2019257540 @default.
• W2968778744 cites W2034536904 @default.
• W2968778744 cites W2044203638 @default.
• W2968778744 cites W2047528606 @default.
• W2968778744 cites W2054935622 @default.
• W2968778744 cites W2068128355 @default.
• W2968778744 cites W2106203584 @default.
• W2968778744 cites W2133624827 @default.
• W2968778744 cites W2134843796 @default.
• W2968778744 cites W2139814250 @default.
• W2968778744 cites W2147634847 @default.
• W2968778744 cites W2163312994 @default.
• W2968778744 cites W2284918527 @default.
• W2968778744 cites W2286756681 @default.
• W2968778744 cites W2322561651 @default.
• W2968778744 cites W2804862438 @default.
• W2968778744 cites W2921033702 @default.
• W2968778744 cites W2992150336 @default.
• W2968778744 cites W4211014057 @default.
• W2968778744 cites W4233955959 @default.
• W2968778744 doi "https://doi.org/10.1016/s2214-109x(19)30336-5" @default.
• W2968778744 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6695526" @default.
• W2968778744 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31402008" @default.
• W2968778744 hasPublicationYear "2019" @default.
• W2968778744 type Work @default.
• W2968778744 sameAs 2968778744 @default.
• W2968778744 citedByCount "7" @default.
• W2968778744 countsByYear W29687787442019 @default.
• W2968778744 countsByYear W29687787442020 @default.
• W2968778744 countsByYear W29687787442022 @default.
• W2968778744 countsByYear W29687787442023 @default.
• W2968778744 crossrefType "journal-article" @default.
• W2968778744 hasAuthorship W2968778744A5001697249 @default.
• W2968778744 hasAuthorship W2968778744A5015999349 @default.
• W2968778744 hasAuthorship W2968778744A5023451391 @default.
• W2968778744 hasAuthorship W2968778744A5028161835 @default.
• W2968778744 hasAuthorship W2968778744A5029342829 @default.
• W2968778744 hasAuthorship W2968778744A5034327769 @default.
• W2968778744 hasAuthorship W2968778744A5041811964 @default.
• W2968778744 hasAuthorship W2968778744A5045009552 @default.
• W2968778744 hasAuthorship W2968778744A5045595046 @default.
• W2968778744 hasAuthorship W2968778744A5056664128 @default.
• W2968778744 hasAuthorship W2968778744A5080359087 @default.
• W2968778744 hasAuthorship W2968778744A5085384499 @default.
• W2968778744 hasAuthorship W2968778744A5086877004 @default.
• W2968778744 hasAuthorship W2968778744A5087241179 @default.
• W2968778744 hasAuthorship W2968778744A5087495070 @default.
• W2968778744 hasBestOaLocation W29687787441 @default.
• W2968778744 hasConcept C112930515 @default.
• W2968778744 hasConcept C126322002 @default.
• W2968778744 hasConcept C141071460 @default.
• W2968778744 hasConcept C142724271 @default.
• W2968778744 hasConcept C168563851 @default.
• W2968778744 hasConcept C204787440 @default.
• W2968778744 hasConcept C27081682 @default.
• W2968778744 hasConcept C2778602436 @default.
• W2968778744 hasConcept C2779234561 @default.
• W2968778744 hasConcept C2779245376 @default.
• W2968778744 hasConcept C3019080777 @default.
• W2968778744 hasConcept C501593827 @default.
• W2968778744 hasConcept C535046627 @default.
• W2968778744 hasConcept C54355233 @default.
• W2968778744 hasConcept C71924100 @default.
• W2968778744 hasConcept C86803240 @default.
• W2968778744 hasConcept C89423630 @default.
• W2968778744 hasConceptScore W2968778744C112930515 @default.
• W2968778744 hasConceptScore W2968778744C126322002 @default.
• W2968778744 hasConceptScore W2968778744C141071460 @default.
• W2968778744 hasConceptScore W2968778744C142724271 @default.
• W2968778744 hasConceptScore W2968778744C168563851 @default.

• next